期刊文献+

468例慢性心力衰竭患者病因和药物应用分析 被引量:3

Analysis of aetiology and treatment for 468 patients with chronic heart failure
原文传递
导出
摘要 目的了解慢性心力衰竭患者的病因和药物应用状况。方法回顾性分析民权县人民医院2004年至2008年住院诊断为慢性心力衰竭患者的临床资料,与2007年中华医学会慢性心力衰竭指南进行比较。结果共分析了468例患者,慢性心力衰竭最常见的病因是冠心病243例(51.9%),其次是高血压病86例(18.4%)。血管紧张素转换酶抑制剂和β-受体阻滞剂的使用率分别为52.7%和42.9%,利尿剂、地高辛和硝酸酯类使用率较高,分别为75.0%、62.8%和80.1%。醛固酮拮抗剂使用率为10.8%。结论 2004年至2008年民权县人民医院慢性心力衰竭患者以冠心病和高血压病为主,药物治疗情况与2007年中华医学会慢性心力衰竭指南的要求存在明显差距。 Objective To investigate the aetiology and pharmaceutical therapy of patients with chronic heart failure in the last five years.Methods Data of hospitalized patients with chronic heart failure from 2004 to 2008 were collected and analysed.Results A total of 468 patients were included.The most common causes for heart failure was coronary heart disease(51.9%),followed by hypertension(18.4%).Angiotensin conversion enzyme inhibitors were used in 52.7% of the patients,and beta blockers were given in 42.9%,diuretics in 75.0%,digoxin in 62.8% and nitrates in 80.1% of the patients.10.8% of the patients were administered aldosterone antagonist.Conclusion The main causes of chronic heart failure in the people's hospital of minquan county from 2004 to 2008 are coronary heart disease and hypertension.More attention should be payed for the standard therapy of chronic heart failure.
出处 《临床医学》 CAS 2010年第8期11-12,共2页 Clinical Medicine
关键词 心力衰竭 充血性 药物疗法 医院 社区 Heart failure Congestive Drug therapy Hospitals Community
  • 相关文献

参考文献4

二级参考文献48

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 2Kalon KL,Joan LP, William BK. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol, 1993,22 (Suppl A):6A-13A.
  • 3Hung YT, Cheug NT, Ip S. Epidemiology of heart failure in Hong Kong,1997. Hong Kong Med J, 2000,6:159-162.
  • 4Packer M, Coats AJS, Fowler MB, et al. For the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effects of carvedilol on survival in severe chronic heart failure. N Engl J Med, 2001, 344:1651-1658.
  • 5Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Eur Heart J, 2001, 22: 1527-1561.
  • 6Hunt HA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the international society for heart and lung transplantation. Circulation, 2001, 104:2996-3007.
  • 7Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 8Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 9Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 10Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.

同被引文献13

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部